XML 80 R7.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Cash Flows from Operating Activities    
Net loss $ (11,843,513) $ (1,467,887)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation and amortization expense 478,191
Bad debt expense 23,500
Impairment expense 3,113,020
Equity based compensation expense 4,643,127 187,156
Recognized loss on marketable securities 160,449 101,208
Gain on sale of asset (27,000)
Expenses paid through financings 15,000
Amortization of debt discount 39,372 1,944
Change in fair value of derivative liability (1,138,604)
Changes in operating assets and liabilities:    
(Increase) decrease in accounts receivable (63,144) 43,388
Increase in prepaid expenses and other current assets (73,620) (14,883)
Increase in accounts payable and accrued liabilities 3,259,458 389,142
Increase in deferred revenue 22,906 4,758
Net cash used in operating activities (1,390,858) (755,174)
Cash Flows from Investing Activities    
Proceeds from sale of marketable securities 68,702 284
Proceeds from sale of asset 27,000
Cash paid for equipment (3,463)
Cash paid for software development (11,500) (72,770)
Net cash provided (used) by investing activities 80,739 (72,486)
Cash Flows from Financing Activities    
Proceeds from notes 45,005 50,000
Payments of notes (105,034) (18,005)
Proceeds from sale of future receivables 424,510
Repayments of receivables sale (27,259)
Deposit on purchase of preferred stock 500,000
Repayment of deposit on purchase of preferred stock (215,000)
Contributions to capital 65,000
Proceeds from sale of common stock 66,668
Proceeds from sale of preferred stock 979,997 300,000
Net cash provided by financing activities 1,602,219 463,663
Net increase (decrease) in cash 292,100 (363,997)
Cash, beginning of year 14,152 378,149
Cash, end of year 306,252 14,152
Supplemental disclosures of cash flow information:    
Cash paid during the period for interest 49,552 53,416
Cash paid during the period for income taxes
Supplemental schedule of non-cash investing and financing activities:    
Preferred stock issued for asset acquisition 8,600,000
Subsidiary preferred shares converted to subsidiary common shares 154,000
Non-cash adjustments to Redeemable Preferred Stock of subsidiary 2,059,764 568,029
Notes payable and accrued interest exchanged for preferred stock 116,380
Noncontrolling interest reclassified to paid-in capital 1,591,221
Accounts payable paid through proceeds of preferred stock 100,000
Accrued compensation paid with common stock 56,250
Value of warrant issued with note 42,000
Accounts payable paid through proceeds of note 4,995
Warrant derivative liability at inception 1,750,646
Accrued compensation forgiven and credited to contributed capital 187,500
Discount attributable to Liability on Sale of Future Revenue 142,491  
Discount attributable to note payable 10,000  
Marketable securities received as payment for Series D preferred stock 240,000
Note and accrued interest forgiven $ 706,501